Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Efficacy and Safety of Remimazolam Besylate for Cardiac Anesthesia
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
Summary
The evidence on the practice of remimazolam besylate during cardiac anesthesia is scarce. This study investigates the efficacy and safety of remimazolam besylate general induction and maintenance during cardiac surgery.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
320
Start Date
2025-01
Completion Date
2025-06
Last Updated
2024-12-05
Healthy Volunteers
No
Conditions
Interventions
remimazolam besylate
Patients received an initial dose of remimazolam (0.3mg/kg) for induction and a continuous infusion rate of 1 mg/kg/h for anesthesia maintenance. Sedative was adjusted to maintain a bispectral index (BIS) at 40-60 after induction.
propofol
Patients received an initial dose of propofol (1.0 mg/kg) and a continuous infusion rate of 1-1.5 mg/kg/h. Sedative was adjusted to maintain a bispectral index (BIS) at 40-60 after induction.